3 Comments
User's avatar
Adam Cifu, MD's avatar

Terrific, to the point post.

Expand full comment
Julia Smith's avatar

This was very interesting!

Expand full comment
Andrew J Foy's avatar

Great post. Data for Watchman is incredibly weak. The regulatory trials PROTECT and PREVAIL rank among the worst, yet most influential, trials I have ever reviewed in my life. It's a disagree IMO that the broader cardiology community has embraced the device to the extent it has without demand for better trial-level evidence.

Expand full comment